Please provide your email address to receive an email when new articles are posted on . An AI-powered device to identify low left ventricular ejection fraction in patients at risk for HF gained 510(k) ...

The device may help boost early detection of HFrEF for people living in low-resource settings where echo is scarce.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leading artificial intelligence (AI)-driven health technology company, announced that the Centers for Medicare & Medicaid Services (CMS) has included its ...

The answer is very clear that if you have MI and preserved EF, there is no benefit of using a beta-blocker. Sripal Bangalore ...

San Francisco, CA, Dec. 18, 2019 (GLOBE NEWSWIRE) -- Eko, a digital health company applying artificial intelligence (AI) in the fight against heart disease, today announced the U.S. Food and Drug ...

August 12, 2011 — Older patients are more likely than younger patients with a similar low left ventricular ejection fraction to have cognitive decline, report researchers. "Cognitive dysfunction due ...

Based on pioneering research from Mayo Clinic, ECG-AI LEF aims to aid physicians in identifying low ejection fraction in patients at risk of heart failure CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, ...

A polypill containing three recommended heart failure therapies improved heart function, reduced hospitalizations and was ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

Among patients with heart failure and reduced ejection fraction (HFrEF), those taking a "polypill" combination of three ...

Dr. Butler answers the question: 'What Is An ACE Inhibitor?' — -- Question: What is an ACE inhibitor, how does it work, and when is it used to treat heart failure? Answer: ACE inhibitors are very ...